Volume 100, Issue 6 pp. 1088-1089
COMMENTARY

“The Hunterian approach: Cordis Smart Stent safe and effective, but what about its use in long or severely calcified chronically occluded lesions… Let's get it done the first time”

Richard R. Heuser MD, FACP, FESC, MSCAI

Corresponding Author

Richard R. Heuser MD, FACP, FESC, MSCAI

College of Medicine, University of Arizona, Phoenix, Arizona, USA

College of Health Solutions, Arizona State University, Tempe, Arizona, USA

Correspondence: Richard R. Heuser, MD, FACP, FESC, MSCAI, College of Medicine, University of Arizona, Phoenix, AZ, USA.

Email: [email protected]

Search for more papers by this author
First published: 29 November 2022

Key Points

  • The Smart stent has been “battle-hardened” with years of experience to treat femoropopliteal lesions.

  • Many patients with femoropopliteal lesions require multiple interventions.

  • Are there any therapies that can be performed for long-term success for longer femoral lesions?

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.